|
|
||
|
|
|
||||||
Huizenga School Hosts Carl Singer for Distinguished Lecture Series
The H. Wayne Huizenga School of Business & Entrepreneurship recently hosted Carl N. Singer, chairman of Viragen, Inc., as a guest speaker for the Distinguished Lecture Series. Singer has served on the Board of Directors for 31 companies, including Sealy, Inc., Scripto, Inc. and the B.V.D. Company, and specializes in fixing “sick companies.” In his second visit to NSU as a guest speaker, he discussed his business philosophies and shared a wealth of experience from leading some of America’s largest corporations. He also talked about identifying signs of a troubled company and problems associated with the improper use of assets, and explained the changing landscape of business, globalization and its impact. Lastly, Singer reminded the audience that there is no substitute for good judgment, common sense and hard work. He quotes his wife as saying, “You’ve just got to work at it.”
Viragen, Inc., is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. The company is publicly traded on the American Stock Exchange (VRA) and its majority-owned subsidiary, Viragen International, Inc., is publicly traded on the Over-The-Counter Bulletin Board (VGNI). Viragen currently employs 62 people with corporate facilities in Plantation, Florida (Headquarters) and research and manufacturing facilities in Edinburgh, Scotland and Umeå, Sweden. The Distinguished Lecture Series is sponsored by BankAtlantic.
|
||||||
|
For more information, please contact Office of Public Affairs This page is maintained by The Office of Public Affairs. . Nova Southeastern University. Revised: May 16, 2006 |